JPH0860181A - Highly unsaturated fatty acid-containing oil and fat - Google Patents
Highly unsaturated fatty acid-containing oil and fatInfo
- Publication number
- JPH0860181A JPH0860181A JP6218300A JP21830094A JPH0860181A JP H0860181 A JPH0860181 A JP H0860181A JP 6218300 A JP6218300 A JP 6218300A JP 21830094 A JP21830094 A JP 21830094A JP H0860181 A JPH0860181 A JP H0860181A
- Authority
- JP
- Japan
- Prior art keywords
- oils
- fats
- fatty acid
- fat
- dha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000021122 unsaturated fatty acids Nutrition 0.000 title abstract description 8
- 150000004670 unsaturated fatty acids Chemical class 0.000 title abstract description 7
- 239000003921 oil Substances 0.000 claims abstract description 55
- 239000003925 fat Substances 0.000 claims abstract description 51
- 235000019197 fats Nutrition 0.000 claims abstract description 51
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 24
- 229930195729 fatty acid Natural products 0.000 claims abstract description 24
- 239000000194 fatty acid Substances 0.000 claims abstract description 24
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 22
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 21
- 239000000470 constituent Substances 0.000 claims abstract description 6
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 claims abstract 3
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 claims abstract 3
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 claims abstract 3
- 125000005456 glyceride group Chemical group 0.000 claims description 11
- 150000003626 triacylglycerols Chemical class 0.000 claims description 6
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 claims description 4
- 235000019198 oils Nutrition 0.000 abstract description 50
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract description 21
- 102000004882 Lipase Human genes 0.000 abstract description 14
- 108090001060 Lipase Proteins 0.000 abstract description 14
- 239000004367 Lipase Substances 0.000 abstract description 14
- 238000006243 chemical reaction Methods 0.000 abstract description 14
- 235000019421 lipase Nutrition 0.000 abstract description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract description 12
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract description 7
- 239000000243 solution Substances 0.000 abstract description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 6
- 235000021323 fish oil Nutrition 0.000 abstract description 6
- 229920000084 Gum arabic Polymers 0.000 abstract description 4
- 239000000205 acacia gum Substances 0.000 abstract description 4
- 235000010489 acacia gum Nutrition 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 235000014593 oils and fats Nutrition 0.000 abstract description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 abstract description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract description 2
- 241000235015 Yarrowia lipolytica Species 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 239000007853 buffer solution Substances 0.000 abstract description 2
- 239000001110 calcium chloride Substances 0.000 abstract description 2
- 229910001628 calcium chloride Inorganic materials 0.000 abstract description 2
- 230000029087 digestion Effects 0.000 abstract description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract description 2
- 241000978776 Senegalia senegal Species 0.000 abstract 1
- 238000000354 decomposition reaction Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 238000006460 hydrolysis reaction Methods 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- -1 fatty acid glycerin esters Chemical class 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000006911 enzymatic reaction Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229920003169 water-soluble polymer Polymers 0.000 description 5
- 239000003513 alkali Substances 0.000 description 4
- 235000021588 free fatty acids Nutrition 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 244000215068 Acacia senegal Species 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 150000004671 saturated fatty acids Chemical class 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 238000005809 transesterification reaction Methods 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 108010085318 carboxymethylcellulase Proteins 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- ITNKVODZACVXDS-YNUSHXQLSA-N ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate Chemical compound CCOC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC ITNKVODZACVXDS-YNUSHXQLSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 239000010698 whale oil Substances 0.000 description 1
Landscapes
- Edible Oils And Fats (AREA)
- Fats And Perfumes (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、ドコサヘキサエン酸
(以下、DHAと略す)を高濃度に含有する天然油脂に
関する。FIELD OF THE INVENTION The present invention relates to natural fats and oils containing docosahexaenoic acid (hereinafter abbreviated as DHA) in a high concentration.
【0002】[0002]
【従来の技術】ω3系高度不飽和脂肪酸を含有するグリ
セリドである天然油脂は、トリグリセリドの形態で魚油
等に多く含まれる。特にDHAは、学習機能改善、抗動
脈硬化性、抗腫瘍性、免疫賦活、抗アレルギー等の有用
な生理活性を有することが知られている。このDHA
は、天然に存在するグリセリドである天然油脂には、構
成脂肪酸中多くても20〜30%であり、この他に大量
のパルミチン酸、ステアリン酸等の飽和脂肪酸や、リノ
ール酸に代表されるω6系高度不飽和脂肪酸が含まれて
いるため、この天然油脂を健康食品や医薬品として使用
する際に脂質過多の面で不都合である。このために、D
HA以外の脂肪酸を低減した油脂が酵素法によって調製
された(Yukihisa Tanaka et a
l,Journal of American Oil
Chemical Society,69,(199
2) 1210−1214)。2. Description of the Related Art Natural fats and oils which are glycerides containing ω3 polyunsaturated fatty acids are often contained in fish oils in the form of triglycerides. In particular, DHA is known to have useful physiological activities such as learning function improvement, anti-arteriosclerotic property, anti-tumor property, immunostimulation and anti-allergy. This DHA
In natural fats and oils that are naturally occurring glycerides, at most 20 to 30% of the constituent fatty acids, and in addition to this, a large amount of saturated fatty acids such as palmitic acid and stearic acid, and ω6 represented by linoleic acid. Since it contains a system polyunsaturated fatty acid, it is inconvenient in terms of excess lipid when this natural fat is used as a health food or a medicine. Because of this, D
Fats and oils with reduced fatty acids other than HA were prepared by an enzymatic method (Yukihisa Tanaka et a.
l, Journal of American Oil
Chemical Society, 69, (199
2) 1210-1214).
【0003】また、遊離の高純度DHAとグリセリンと
を原料に用いたリパーゼの合成反応や、高純度DHAエ
チルエステルとのリパーゼのエステル交換反応を利用し
て調製した高濃度DHA油脂に関する報告(田中幸久
等、油化学、41巻、1992年、563ー567頁お
よび特開平5ー331105)がなされている。A report on high-concentration DHA oils and fats prepared by utilizing a lipase synthesis reaction using free high-purity DHA and glycerin as raw materials and a transesterification reaction of lipase with high-purity DHA ethyl ester (Tanaka Yukihisa et al., Oil Chemistry, Vol. 41, 1992, pp. 563-567 and JP-A-5-331105).
【0004】[0004]
【発明が解決しようとする課題】上記に報告されている
ように、従来の技術では、リパーゼを用いた脂肪酸種に
対する最適な選択加水分解反応により得られる油脂です
ら、構成脂肪酸中のDHA含量が53%であり、グリセ
リドの75%がトリグリセリド、24%がジグリセリ
ド、1%がモノグリセリドのトリグリセリドを主成分と
するものであった。また、リパーゼの合成反応やエステ
ル交換反応によって調製した油脂は、トリグリセリドか
らなるものであった。一般に食物として摂取されたトリ
グリセリドは、膵臓から分泌される消化酵素であるリパ
ーゼの作用により、ジグリセリドを経由して遊離の脂肪
酸とモノグリセリドとに加水分解され、分解されたモノ
グリセリドと遊離の脂肪酸は、胆汁酸塩とミセルを形成
し吸収されることが知られている。しかし、トリグリセ
リドからなる油脂は、分子内に親水性残基を有しないた
めに、水系に分散させるには高濃度の分散剤の使用や超
音波処理等の操作が必須であった。以上の点に鑑みて、
本発明は、水への分散性がよく、吸収性の良好な天然油
脂を提供することを目的とするものである。DISCLOSURE OF THE INVENTION Problems to be Solved by the Invention As reported above, in the prior art, even fats and oils obtained by the optimum selective hydrolysis reaction of fatty acid species using lipase have a DHA content in the constituent fatty acids. It was 53%, 75% of the glyceride was triglyceride, 24% was diglyceride, and 1% was monoglyceride. The fats and oils prepared by the lipase synthesis reaction and transesterification reaction were composed of triglycerides. In general, triglyceride ingested as food is hydrolyzed into free fatty acid and monoglyceride via diglyceride by the action of lipase, which is a digestive enzyme secreted by the pancreas, and the decomposed monoglyceride and free fatty acid are bile. It is known that it forms micelles with acid salts and is absorbed. However, since fats and oils composed of triglycerides do not have hydrophilic residues in the molecule, it is necessary to use a high-concentration dispersant or an operation such as ultrasonic treatment in order to disperse them in an aqueous system. In view of the above points,
An object of the present invention is to provide a natural fat or oil which has good dispersibility in water and good absorbability.
【0005】[0005]
【課題を解決するための手段】本発明者らは、上記課題
を解決するため鋭意研究を行った結果、目的を達成でき
る天然油脂として、DHAを高濃度に含有し、飽和脂肪
酸含量が少ない天然油脂を得ることに成功し、本発明を
完成するに到った。Means for Solving the Problems As a result of intensive studies to solve the above-mentioned problems, the present inventors have found that natural fats and oils containing a high concentration of DHA and having a low saturated fatty acid content are natural fats and oils that can achieve the object. Succeeding in obtaining fats and oils, the present invention has been completed.
【0006】すなわち、本発明は、油脂の構成脂肪酸の
うちDHAを60%以上含有し、トリグリセリド、ジグ
リセリド、モノグリセリドから構成され、かつ、ジグリ
セリド、モノグリセリドの総量が油脂の80%以上であ
り、あるいはトリグリセリド以外のグリセリド中ジグリ
セリドの比率が70%以上であることを特徴とする天然
油脂に関するものである。以下、本発明をさらに詳細に
説明する。That is, the present invention contains 60% or more of DHA among fatty acids constituting fats and oils and is composed of triglycerides, diglycerides and monoglycerides, and the total amount of diglycerides and monoglycerides is 80% or more of fats and oils, or triglycerides. The present invention relates to natural fats and oils characterized in that the ratio of diglyceride in glycerides other than is 70% or more. Hereinafter, the present invention will be described in more detail.
【0007】本発明でいう天然油脂とは、天然に存在す
る脂肪酸グリセリンエステルまたは天然に存在する脂肪
酸グリセリンエステルを酵素分解して得られる脂肪酸グ
リセリンエステルを指す。本発明で得られる高濃度DH
A含有油脂の原料としては、DHAを豊富に含む魚油、
鯨油等の海産性天然油脂や微生物由来の天然油脂を使用
することができる。これらの油脂を脂肪酸種に対する特
異性を利用して、DHA以外の一般脂肪酸を選択的に加
水分解すればよいのであるが、加水分解に適した酵素と
しては、DHAに対して基質特異性の低いリパーゼであ
り、特にキャンディダ・シリンドラセやキャンディダ・
リポリティカ由来の酵素が好ましい。The term "natural fats and oils" as used in the present invention means naturally occurring fatty acid glycerin esters or fatty acid glycerin esters obtained by enzymatically decomposing naturally occurring fatty acid glycerin esters. High concentration DH obtained by the present invention
As a raw material for A-containing fats and oils, fish oil rich in DHA,
Marine-derived natural fats and oils such as whale oil and natural fats and oils derived from microorganisms can be used. It is only necessary to selectively hydrolyze general fatty acids other than DHA by utilizing the specificity of these fats and oils for fatty acid species, but an enzyme suitable for hydrolysis has a low substrate specificity for DHA. Lipase, especially Candida Cyrindrace and Candida
Enzymes from lipolytica are preferred.
【0008】上記の酵素により酵素反応を行なっても、
基質である油脂の他には水のみしか使用しない従来法に
よっては、DHAを60%以上の高濃度に含有し、本発
明で規定する組成の天然油脂を得ることはできない。本
発明においては、リパーゼ反応を行なう際に、反応系に
水溶性高分子化合物を添加することによって、目的とす
る天然油脂を得ることができたのである。Even when an enzymatic reaction is carried out with the above-mentioned enzyme,
According to the conventional method of using only water in addition to the oil and fat as a substrate, it is impossible to obtain a natural oil and fat containing DHA in a high concentration of 60% or more and having the composition defined in the present invention. In the present invention, the desired natural fat or oil could be obtained by adding the water-soluble polymer compound to the reaction system when carrying out the lipase reaction.
【0009】リパーゼの反応系に添加する水溶性高分子
化合物は、リパーゼ反応を阻害しない性質のものであれ
ばよく、天然由来でも合成高分子化合物でもよい。天然
由来の水溶性高分子化合物としては、可溶性澱粉、デキ
ストリン、デキストラン、ペクチン、アラビアゴム、キ
サンタンガム等の天然高分子糖類化合物、ゼラチン、コ
ーン蛋白質由来ペプチド等のアミノ酸高分子化合物、カ
ルボキシメチルセルローズ等のセルロース誘導体等を使
用することができる。合成高分子化合物としては、ポリ
ビニールアルコール等を使用することができる。リパー
ゼの反応系に添加するこれらの水溶性高分子化合物の濃
度は、使用する油脂の濃度によっても変化するが、カル
ボキシメチルセルラース、カチナール、ペクチン、キサ
ンタンガム等の化合物では0.1〜5%の範囲で使用で
き、好ましくは0.5〜2%であり、ゼラチン、コーン
由来ペプチド、可溶性澱粉、デキストラン、アラビアゴ
ム等の化合物では1〜20%の範囲で使用でき、好まし
くは2〜5%である。The water-soluble polymer compound added to the lipase reaction system may be of a nature that does not inhibit the lipase reaction, and may be a naturally-occurring polymer compound or a synthetic polymer compound. Examples of naturally-derived water-soluble polymer compounds include soluble starch, dextrin, dextran, pectin, gum arabic, natural polymer saccharide compounds such as xanthan gum, gelatin, amino acid polymer compounds such as corn protein-derived peptides, and carboxymethyl cellulose. A cellulose derivative or the like can be used. Polyvinyl alcohol or the like can be used as the synthetic polymer compound. The concentration of these water-soluble polymer compounds added to the reaction system of lipase varies depending on the concentration of fats and oils used, but in the case of compounds such as carboxymethylcellulase, catalan, pectin and xanthan gum, the concentration is 0.1 to 5%. It can be used in the range, preferably 0.5 to 2%, and in compounds such as gelatin, corn-derived peptide, soluble starch, dextran and gum arabic, it can be used in the range of 1 to 20%, preferably 2 to 5%. is there.
【0010】上記酵素で加水分解する反応は、酵素の活
性を発現するのに十分の量の水の存下で行うが、その量
は、油脂に対して1〜300%であり、好ましくは40
〜100%程度である。前記酵素の使用量は、基質に含
有される高度不飽和脂肪酸の濃度、反応温度、反応p
H、反応時間によっても変わるが、油脂1gあたり10
〜1000ユニット(U)であり、好ましくは50〜3
00ユニット(U)程度である。反応温度はリパーゼが
失活しない範囲(20〜60℃)で適宜選ぶことができ
るが、特に好ましくは25〜40℃である。The above-mentioned enzyme-hydrolyzing reaction is carried out in the presence of a sufficient amount of water for expressing the activity of the enzyme, and the amount thereof is 1 to 300% with respect to the oil and fat, preferably 40.
It is about 100%. The amount of the enzyme used depends on the concentration of highly unsaturated fatty acid contained in the substrate, the reaction temperature, the reaction p
H, 10 depending on 1g of fats and oils, depending on the reaction time
To 1000 units (U), preferably 50 to 3
It is about 00 units (U). The reaction temperature can be appropriately selected within a range (20 to 60 ° C.) in which lipase is not inactivated, and particularly preferably 25 to 40 ° C.
【0011】また、加水分解の反応におけるpHを一定
に保つために、水の代わりに緩衝液を用いてもよい。p
Hは7〜9の範囲で反応できるが、特に好ましくは7.
5〜8.5である。さらに、加水分解の反応を速めるた
めに、カルシウムやマグネシウム等の2価の金属イオン
を反応液に添加してもよい。その濃度は10〜500m
Mの範囲で使用できるが、特に好ましくは150〜25
0mMのカルシウムイオンを用いる。酵素反応は空気の
存在下でも十分に問題なく進行するが、一般的に高度不
飽和脂肪酸は酸化されやすいので、窒素やアルゴンガス
等の不活性ガス用いて、酸素を制限した環境下で反応を
行う方が好ましい。A buffer solution may be used instead of water in order to keep the pH constant in the hydrolysis reaction. p
H can react in the range of 7 to 9, but particularly preferably 7.
It is 5 to 8.5. Furthermore, in order to accelerate the hydrolysis reaction, divalent metal ions such as calcium and magnesium may be added to the reaction solution. The concentration is 10-500m
It can be used in the range of M, but particularly preferably 150 to 25
0 mM calcium ion is used. The enzymatic reaction proceeds well in the presence of air, but in general, highly unsaturated fatty acids are easily oxidized, so use an inert gas such as nitrogen or argon gas to perform the reaction in an environment where oxygen is limited. It is preferable to carry out.
【0012】油脂の加水分解率は、遊離した脂肪酸をア
ルカリで滴定して測定する方法やガスクロマトグラフィ
ー等の方法で求めることができるが、脂肪酸種の総量と
脂肪酸種の分離定量が同時にできるガスクロマトグラフ
ィーが測定精度の点で有利である。加水分解の測定は次
式により求めた。The hydrolysis rate of fats and oils can be determined by a method of titrating free fatty acids with an alkali or by a method such as gas chromatography. However, the total amount of fatty acid species and the amount of fatty acid species can be separated and quantified at the same time. Chromatography is advantageous in terms of measurement accuracy. The hydrolysis was determined by the following formula.
【数1】 加水分解率は60〜80%の範囲になるように制御すれ
ばよいが、好ましくは65〜75%である。[Equation 1] The hydrolysis rate may be controlled so as to fall within the range of 60 to 80%, preferably 65 to 75%.
【0013】上記の酵素を使用し、酵素反応を行なう際
に、反応系に水溶性高分子化合物を添加することによ
り、高度不飽和脂肪酸含有油脂に含まれる高度不飽和脂
肪酸エステルを殆ど加水分解しないか、もしくは加水分
解してもその程度は極めて低いので、高度不飽和脂肪酸
以外の脂肪酸は優先的に加水分解されるために、これを
除去し未分解で残存するグリセリドを分離回収すれば、
高度不飽和脂肪酸特にDHAを高濃度に含有するジグリ
セリド、モノグリセリドを主成分とする油脂を得ること
ができる。上記のリパーゼによる加水分解油よりグリセ
リド(天然油脂)画分を採取するには、通常行われてい
るアルカリ脱酸法、水蒸気蒸留法、イオン交換樹脂によ
る分画、分子蒸留、吸着クロマト等の手段を利用すれば
よく、特にその方法は問わい。When the above enzyme is used and an enzymatic reaction is carried out, a water-soluble polymer compound is added to the reaction system to hardly hydrolyze the highly unsaturated fatty acid ester contained in the highly unsaturated fatty acid-containing oil or fat. Or, even if it is hydrolyzed, the degree is extremely low, so fatty acids other than highly unsaturated fatty acids are preferentially hydrolyzed, so if this is removed and the undegraded residual glyceride is separated and recovered,
It is possible to obtain a diglyceride containing a highly unsaturated fatty acid, especially DHA at a high concentration, or an oil or fat containing a monoglyceride as a main component. In order to collect the glyceride (natural oil and fat) fraction from the hydrolyzed oil by the above lipase, the usual methods such as alkali deoxidation method, steam distillation method, fractionation by ion exchange resin, molecular distillation, adsorption chromatography, etc. Can be used, and the method is not particularly limited.
【0014】[0014]
【発明の効果】本発明の天然油脂は、DHAを高濃度に
含有し、ジグリセリド、モノグリセリドを主成分として
いるため消化吸収に優れており、また、飽和脂肪酸の含
有率が極めて低いためにエネルギー過剰摂取の問題が少
なく、さらに、水系で使用する際に良好な分散性を有し
ており、DHAの有用な生理活性を発現しやすく成人病
の予防や治療に有効に用いられる。Industrial Applicability The natural fats and oils of the present invention are excellent in digestion and absorption because they contain DHA in a high concentration and have diglyceride and monoglyceride as the main components, and the saturated fatty acid content is extremely low, resulting in excess energy. It has few problems of ingestion, has good dispersibility when used in an aqueous system, and easily develops useful physiological activity of DHA, and is effectively used for prevention and treatment of adult diseases.
【0015】[0015]
【実施例】以下に、実施例を挙げて本発明をさらに詳細
に説明するが、本発明は、これによりなんら限定される
ものではない。 (実施例1)0.05Mトリスー塩酸緩衝液(pH8.
2)、0.2M塩化カルシウム、5%アラビアゴムから
構成される反応液100mlに12,500ユニットの
キャンディダ・リポリティカ由来のリパーゼ(天野製薬
社製)を溶解し、さらに、マグロ頭部より採取した魚油
A(脂肪酸組成は表1に記載)10gを混合して45℃
で15時間撹拌し、2N水酸化ナトリウムで連続的にp
Hを8.2に調整しながら加水分解反応を行い、分解油
を得た。ヘキサン100mlで油脂を抽出し、遠心分離
(3,000回転、10分間)後、ヘキサン層を回収し
た。この抽出液に40mlのアセトン、次いで、20m
lの0.3N水酸化ナトリウム溶液を加え、室温で1時
間撹拌した。遊離の脂肪酸が除去されたグリセリドがヘ
キサン層に回収でき、溶媒を減圧下で溜去した重量は
2.3gであった。本品をアルカリで鹸化後、メチルエ
ステル誘導体に変換し、ガスクロマトグラフィー法によ
り脂肪酸組成を測定した。その測定結果を表1に示し
た。脂肪酸中のDHA含量は63.9%であった。The present invention will be described in more detail below with reference to examples, but the present invention is not limited thereto. (Example 1) 0.05 M Tris-HCl buffer (pH 8.
2) Dissolve 12,500 units of Candida lipolytica-derived lipase (manufactured by Amano Pharmaceutical Co., Ltd.) in 100 ml of a reaction solution composed of 0.2 M calcium chloride and 5% gum arabic, and collect from the head of tuna. 45g of mixed fish oil A (fatty acid composition is shown in Table 1)
Stir at room temperature for 15 hours and p-p continuously with 2N sodium hydroxide.
Hydrolysis reaction was performed while adjusting H to 8.2 to obtain decomposed oil. The oil and fat was extracted with 100 ml of hexane, and after centrifugation (3,000 rotations, 10 minutes), the hexane layer was collected. Add 40 ml of acetone to this extract, then 20m
l 0.3N sodium hydroxide solution was added, and the mixture was stirred at room temperature for 1 hour. The glyceride from which the free fatty acid was removed could be recovered in the hexane layer, and the weight of the solvent distilled off under reduced pressure was 2.3 g. This product was saponified with an alkali, converted into a methyl ester derivative, and the fatty acid composition was measured by gas chromatography. The measurement results are shown in Table 1. The DHA content in fatty acid was 63.9%.
【0016】(実施例2)実施例1に示した魚油Aを他
の原料である魚油B(脂肪酸組成は表2に記載)に変え
て、他は同じ条件で酵素反応と抽出、精製を行い、最終
的に3.4gのグリセリドを得た。その脂肪酸組成を表
2に示した。本品をアルカリで鹸化後、メチルエステル
誘導体に変換し、ガスクロマトグラフィー法により脂肪
酸組成を測定した。その測定結果を表1に示した。脂肪
酸中のDHA含量は63.2%であった。(Example 2) The fish oil A shown in Example 1 was changed to another raw material, fish oil B (fatty acid composition is shown in Table 2), and the other conditions were the same and the enzymatic reaction, extraction and purification were carried out. Finally, 3.4 g of glyceride was obtained. The fatty acid composition is shown in Table 2. This product was saponified with an alkali, converted into a methyl ester derivative, and the fatty acid composition was measured by gas chromatography. The measurement results are shown in Table 1. The DHA content in fatty acids was 63.2%.
【0017】[0017]
【表1】 [Table 1]
【0018】[0018]
【表2】 [Table 2]
【0019】(実施例3)実施例1で得られた油脂1g
をクロロホルム:アセトン(95:4、v/v)5ml
に溶解し、同じ組成の混合溶媒に懸濁し充填したシリカ
ゲルカラムにかけ、同一組成の混合溶媒で溶出した。薄
層クロマトにより各グリセリドを検出してトリグリセリ
ド、ジグリセリドを含む画分を得(200ml)、次い
で、この画分を減圧下で溶媒を溜去して0.78gの油
脂を得た。実施例2および実施例3で得られた油脂につ
いて、イアトロスキャンを用いてグリセリドの組成を測
定した。結果を表3に示した。(Example 3) 1 g of the oil / fat obtained in Example 1
5 ml of chloroform: acetone (95: 4, v / v)
The solution was dissolved in, and applied to a silica gel column suspended and packed in a mixed solvent of the same composition, and eluted with the mixed solvent of the same composition. Each glyceride was detected by thin layer chromatography to obtain a fraction containing triglyceride and diglyceride (200 ml). Then, the solvent was distilled off from this fraction under reduced pressure to obtain 0.78 g of oil and fat. With respect to the fats and oils obtained in Example 2 and Example 3, the glyceride composition was measured using an iatroscan. The results are shown in Table 3.
【0020】[0020]
【表3】 [Table 3]
【0021】また、実施例2、実施例3で得られた油脂
および魚油B各々0.2gを2mlの精製水に加え、ホ
モゲナイザー(0℃、6000回転)で5分間処理し
た。処理後の油脂分散液を4℃に20時間静置して、そ
の状態変化を観察した。表4に結果を示した。Further, 0.2 g of each of the fats and oils and fish oil B obtained in Examples 2 and 3 was added to 2 ml of purified water and treated with a homogenizer (0 ° C., 6000 rpm) for 5 minutes. The treated oil / fat dispersion was allowed to stand at 4 ° C. for 20 hours, and its state change was observed. The results are shown in Table 4.
【0022】[0022]
【表4】 −: 油脂と水とが2層に完全に分離 +++: 完全に分散した状態で2層に分離していない ++: 分散状態は良好であるが、一部僅かに分離した
状態[Table 4] -: Oil and fat completely separated into two layers +++: Completely dispersed state but not separated into two layers ++: Dispersed state is good, but partly slightly separated state
【0023】また、実施例2および実施例3で得られた
油脂を、表5に示した条件で35℃で2週間静置した
後、油脂の分析をイヤトロスキャンを用いて行った。結
果を表6に示した。実施例3で得られた油脂は、水溶液
でも油脂の状態でも安定であったが、実施例2で得られ
た油脂は、モノグリセリドが水溶液状態でのみ僅かに分
解を受けた。The fats and oils obtained in Examples 2 and 3 were allowed to stand at 35 ° C. for 2 weeks under the conditions shown in Table 5, and then the fats and oils were analyzed using an ear troscan. The results are shown in Table 6. The fats and oils obtained in Example 3 were stable both in an aqueous solution and in the state of fats and oils, but in the fats and oils obtained in Example 2, monoglycerides were slightly decomposed only in an aqueous solution state.
【0024】[0024]
【表5】 *A−D共に密閉容器を使用して気相は窒素で置換し
た。[Table 5] * Both A and D used closed containers and the gas phase was replaced with nitrogen.
【0025】[0025]
【表6】 [Table 6]
Claims (2)
ン酸(DHA)を60%以上含有し、ジグリセリド、モ
ノグリセリドの総量が油脂の80%以上である天然油
脂。1. A natural fat or oil containing 60% or more of docosahexaenoic acid (DHA) among the constituent fatty acids of fats and oils and having a total amount of diglycerides and monoglycerides of 80% or more of the fats and oils.
ン酸(DHA)を60%以上含有し、トリグリセリド以
外のグリセリド中ジグリセリドの比率が70%以上であ
る天然油脂。2. A natural fat or oil containing docosahexaenoic acid (DHA) in an amount of 60% or more of the constituent fatty acids of the fat and oil and having a diglyceride ratio in glycerides other than triglycerides of 70% or more.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21830094A JP3526632B2 (en) | 1994-08-22 | 1994-08-22 | Fats and oils containing highly unsaturated fatty acids |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21830094A JP3526632B2 (en) | 1994-08-22 | 1994-08-22 | Fats and oils containing highly unsaturated fatty acids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0860181A true JPH0860181A (en) | 1996-03-05 |
| JP3526632B2 JP3526632B2 (en) | 2004-05-17 |
Family
ID=16717683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21830094A Expired - Fee Related JP3526632B2 (en) | 1994-08-22 | 1994-08-22 | Fats and oils containing highly unsaturated fatty acids |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3526632B2 (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001010989A1 (en) * | 1999-08-03 | 2001-02-15 | Kao Corporation | Fat compositions |
| US6448292B2 (en) | 2000-03-21 | 2002-09-10 | Kao Corporation | Oil composition |
| JP2002322490A (en) * | 2001-04-26 | 2002-11-08 | Kao Corp | Oil composition |
| WO2004052115A1 (en) * | 2002-12-06 | 2004-06-24 | Abbott Laboratories | Glyceride compositions and methods of making and using same |
| US6762203B2 (en) | 1999-08-03 | 2004-07-13 | Kao Corporation | Oil composition |
| JP2007262079A (en) * | 2007-05-18 | 2007-10-11 | Kao Corp | Oil composition |
| JP2009013179A (en) * | 2008-08-11 | 2009-01-22 | Kao Corp | Insulin resistance improving agent |
| US20090318553A1 (en) * | 2005-05-12 | 2009-12-24 | Proyecto Empresarial Brudy, S.L. | Use Of Docosahexaenoic Glycerides For The Treatment Of Tumorous Diseases |
| CN110139645A (en) * | 2016-12-23 | 2019-08-16 | 巴斯夫有限公司 | For preventing and/or treating cachectic omega-3 fatty acid composition |
-
1994
- 1994-08-22 JP JP21830094A patent/JP3526632B2/en not_active Expired - Fee Related
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6762203B2 (en) | 1999-08-03 | 2004-07-13 | Kao Corporation | Oil composition |
| WO2001010989A1 (en) * | 1999-08-03 | 2001-02-15 | Kao Corporation | Fat compositions |
| US6852758B2 (en) | 1999-08-03 | 2005-02-08 | Kao Corporation | Oil composition |
| US6448292B2 (en) | 2000-03-21 | 2002-09-10 | Kao Corporation | Oil composition |
| EP1135991A3 (en) * | 2000-03-21 | 2002-09-18 | Kao Corporation | Oil composition and use thereof |
| JP2002322490A (en) * | 2001-04-26 | 2002-11-08 | Kao Corp | Oil composition |
| WO2004052115A1 (en) * | 2002-12-06 | 2004-06-24 | Abbott Laboratories | Glyceride compositions and methods of making and using same |
| US20090318553A1 (en) * | 2005-05-12 | 2009-12-24 | Proyecto Empresarial Brudy, S.L. | Use Of Docosahexaenoic Glycerides For The Treatment Of Tumorous Diseases |
| EP1881824B1 (en) * | 2005-05-12 | 2014-12-24 | Brudy Technology, S.L. | Use of docosahexaenoic triglycerides for the treatment of tumorous diseases |
| US9271954B2 (en) * | 2005-05-12 | 2016-03-01 | Brudy Technology, S.L. | Use of docosahexaenoic glycerides for the treatment of tumorous diseases |
| JP2007262079A (en) * | 2007-05-18 | 2007-10-11 | Kao Corp | Oil composition |
| JP2009013179A (en) * | 2008-08-11 | 2009-01-22 | Kao Corp | Insulin resistance improving agent |
| CN110139645A (en) * | 2016-12-23 | 2019-08-16 | 巴斯夫有限公司 | For preventing and/or treating cachectic omega-3 fatty acid composition |
| JP2020503388A (en) * | 2016-12-23 | 2020-01-30 | ビーエーエスエフ エーエス | Omega-3 fatty acid composition for preventing and / or treating cachexia |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3526632B2 (en) | 2004-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3526632B2 (en) | Fats and oils containing highly unsaturated fatty acids | |
| JPH08214892A (en) | Method for producing partially unsaturated glyceride containing highly unsaturated fatty acid | |
| JP3840459B2 (en) | Glyceride and method for producing the same | |
| JP3340182B2 (en) | Method for producing triglyceride containing docosahexaenoic acid | |
| JP3689443B2 (en) | Process for producing highly unsaturated fatty acid-containing glycerides | |
| JPH11263750A (en) | Long-chain unsaturated fatty acid menthol ester and its production by enzymatic method | |
| EP0421867A1 (en) | Method of preparing a glyceride mixture enriched in gamma linolenic and stearidonic acid | |
| JP3853767B2 (en) | Conjugated fatty acid menthol ester and method for producing the same | |
| JPH06116585A (en) | Method for purifying fat and oil | |
| JP2545480B2 (en) | Functional food material | |
| JP2004248671A (en) | Method for purification of conjugated linoleic acid isomer and application of the same | |
| JP3719732B2 (en) | Process for producing highly unsaturated fatty acid glycerides | |
| JPH07268382A (en) | Production of fats and oils containing long-chain highly unsaturated fatty acid | |
| JP2007070486A (en) | Glyceride and method for producing the same | |
| JPH01215286A (en) | Modification of enzyme and hydrolysis of fat and oil | |
| JPH09296197A (en) | Dehydration and purification of oil and fat | |
| JP7382942B2 (en) | Method for producing glyceride containing docosahexaenoic acid using lipase hydrolysis reaction | |
| JP4510045B2 (en) | Method for purifying conjugated linoleic acid isomers and uses thereof | |
| JPS6115692A (en) | Method of concentration of long-chain highly unsaturated fatty acid glyceride | |
| JP5000035B2 (en) | Process for producing glyceride containing docosapentaenoic acid | |
| JPH0889265A (en) | Method for producing triglyceride containing highly unsaturated fatty acid | |
| JPH09206088A (en) | Method for concentrating highly unsaturated long chain fatty acid in phospholipid | |
| JP3088034B2 (en) | Waste oil treatment method and waste oil treatment agent | |
| HK40052701A (en) | Production method for docosahexaenoic acid-containing glyceride using a lipase hydrolysis reaction | |
| JPH01187089A (en) | Production of palmitoleic acid and glyceride thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20031202 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040122 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040217 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040217 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| LAPS | Cancellation because of no payment of annual fees |